TREATMENT OF CANINE TRANSMISSIBLE VENEREAL TUMOR IN FEMALE LABRADOR RETRIEVER WITH EXCISION AND CHEMOTHERAPY: A CASE REPORT

  • Nadia Eprillia Sary Darma Ni Komang Sundara Vet Bali. Jl. Pratu Made Rambug No.2, Batubulan, Kec. Sukawati, Kabupaten Gianyar, Bali, Indonesia, 80237
  • I Gusti Agung Gede Putra Pemayun Laboratorium Ilmu Bedah dan Radiologi Veteriner, Fakultas Kedokteran Hewan, Universitas Udayana, Jl. PB. Sudirman, Denpasar, Bali, Indonesia, 80234

Abstract

Canine transmissible venereal tumor (CTVT) or known as infectious sarcoma, is a genital tumor that is transmitted through sexual contact, bites or licks on the tumor lesion area. A 7-year-old Labrador Retriever with 40 kg of body weight was examined with a complaint of a mass on the vulva with blood discharge. Histopathological examination showed the presence of CTVT tumor cells with homogeneous polyhedral cells and arranged in stroma. Treatment is done by excision of the tumor mass. Premedication was given atropine sulfate (0.02 mg/kg) intramuscularly and 15 minutes later was induced by combination xylazine (1 mg/kg) and ketamin (10 mg/kg) intramuscularly.  Postoperatively, the antibiotic amoxicillin (7 mg/kg) was administered intramuscularly and the antibiotic amoxicillin 500 mg (15 mg/kg) was administered on the second postoperative day, given orally three times a day for five days. On the 5th postoperative day, the tumor incision wound had dried up and the swelling of the vulva was much reduced, but there was still blood discharge indicating the presence of venereal cells that were left behind. The first dose of chemotherapy using vincristine sulfate (0.025 mg/kg) was given on the seventh postoperative day with one-week interval. The blood discharge was gone on the 7th day after the first chemo. The conclusion is, the treatment of CTVT cases with excision method accompanied with chemotherapy gives good results on patient’s recovery. It’s recommended to perform hematology and echocardiography test before chemotherapy to ensure the patient is in stable condition.

Downloads

Download data is not yet available.

References

Abeka YT. 2019. Review on Canine Transmissible Venereal Tumor (CTVT). Can. Ther. Oncol. Int. J. 14(4): 1-9.
Athar M, Suhail A, Muhammad G, Shakoor A, Azim F. 2001. Clinico-therapeutic studies oncanine transmissible venereal tumour. Pak. Vet. J. 21(1): 39-43.
Dar RR, Sheikh TS, Abdul R, John MW, Pooja D, Amir AS, Rohini G, Neeti L, Ganaie MY. 2017. Cytological diagnosis and treatment of transmissible venereal tumor in dog. A case study. Int. J. Cur. Microbiol. Appl. Sci. 6(10): 1365-1369.
Das U, Das A. 2000. Review of canine transmissible venereal sarcoma. Vet. Res. Com. 24: 545-556.
Donald M. 2002. Tumors in domestic animals. 4th edn. America: Lowa State Press.
Ferreira AJ, Jaggy A, Varejao AP, Ferreire MLP, Correia JMJ, Mulas JM, Almeida O, Oliveira P, Prada J. 2000. Brain and ocular metastases from a transmissible venereal tumor in a dog. J. Small Anim. Pract. 41: 165-168.
Ganguly B, Das U, Das AK. 2016. Canine transmissible venereal tumor: a review. Vet Comp Oncology. 14: 1-12.
Gonzalez C, Sanchez B, Velez H, Buen D. 1997. Neoplasms of the reproductive system in bitches: Retrospective study over 6 years. Vet. Mex. 28: 31-34.
Hasamnis AA, Mohanty BK, Muralikrishna PS. 2010. Evaluation of wound healing effect of topical phenytoin on excisional wound in albino Rats. J. Young. Pharm. 2(1): 59-62.
Hiblu MA, Khabuli NM, Gaja AO. 2019. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya. Oper. Vet. J. 9(2): 103-105.
Kabuusu R, Stroup D, Fernandez C. 2010. Risk factors and characteristic of canine transmissible venereal tumors in Grenada West Indies. Vet. Comp. Oncol. 8(1): 50-55.
Khasraw M, Faraj H, Sheikha A. 2010. Thrombocytopenia in solid tumor. Eur. J. Clin. Med. Oncol. 2(2): 89-92.
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. 2008. Development and validation of a predictive model for chemotherapy associated thrombosis. Blood. 111(10): 4902-4907.
Liu C, Wang Y, Lin C, Chuang T, Liao K. 2008. Transient down regulated on of monocyte-derived dendritic cell differentiation, function, and survival during tumor progression and regression in an in vivo canine model of transmissible venereal tumor. Can. Immunol. 57(4): 479-491.
Martins M, De-Souza M, Ferreira F, Gobello C. 2005. Canine transmissible venereal tumor: etiology, pathology, diagnosis and treatment. England, 25 Mei 2006. Pp. 1-8.
Nak D, Nak Y, Cangul IT, Tuna B. 2005. A clinic-pathological study on the effect of vincristine on transmissible venereal tumor in the dog. J. Vet. Med. 52(7): 366-370.
Ostrander EA, Davis BW, Ostranser GK. 2016 Transmissible tumors: breaking the cancer paradigm. Trends. Genet. 32: 1-15.
Pashkevych I, Stybel V, Soroka N. 2018. Diagnostik method of canine transmissible venereal sarcoma. Health Sci. (3): 67-76.
Setthawongsin C, Teewasutrakui P, Sirikachorn T, Techangamsuwan S, Rungsipipat A. 2019. Conventional- vincristine sulfate vs modified protocol of vincristine sulfate and L-asparaginase in Canine Transmissible Venereal Tumor. Front. Vet. Sci. 6:1-12.
Strakova A, Murchison EP. 2015. The cancer which survived: Insights from the genome of an 11000-year-old cancer. Cur. Opin. Genet. Dev. 30: 49-55.
Published
2022-08-07
How to Cite
NI KOMANG, Nadia Eprillia Sary Darma; PEMAYUN, I Gusti Agung Gede Putra. TREATMENT OF CANINE TRANSMISSIBLE VENEREAL TUMOR IN FEMALE LABRADOR RETRIEVER WITH EXCISION AND CHEMOTHERAPY: A CASE REPORT. Buletin Veteriner Udayana, [S.l.], p. 369-376, aug. 2022. ISSN 2477-2712. Available at: <https://ojs.unud.ac.id/index.php/buletinvet/article/view/88687>. Date accessed: 21 nov. 2024. doi: https://doi.org/10.24843/bulvet.2023.v15.i03.p04.
Section
Articles